Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Emerging Company Profile

Function: using CRISPR to match patients to treatments

San Diego start-up advancing precision oncology with $28 million series A financing led by Andreessen Horowitz and Section 32

By Richard Guy, Biopharma Analyst
May 5, 2023 12:10 AM UTC

Function Oncology is using its CRISPR-based functional genomics platform to help physicians select the right treatments for cancer patients, and drug developers identify new targets. The company launched on April 12 with a $28 million series A financing led by Andreessen Horowitz and Section 32.

CEO Srinath Sampath told BioCentury he was inspired to start Function Oncology Inc. by the outliers in waterfall plots used to report the results of Phase I and II cancer trials. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Function Oncology Inc.